ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0632

Adiposity Increases Kidney Stone Disease Risk via Renal Fat Depots and Natriuresis

Session Information

Category: Genetic Diseases of the Kidneys

  • 1202 Genetic Diseases of the Kidneys: Complex Kidney Traits

Authors

  • Lovegrove, Catherine E., University of Oxford Nuffield Department of Surgical Sciences, Oxford, England, United Kingdom
  • Thanaj, Marjola, University of Westminster, London, England, United Kingdom
  • Aggarwal, Prashant, University of Oxford Nuffield Department of Surgical Sciences, Oxford, England, United Kingdom
  • Basty, Nicolas, University of Westminster, London, England, United Kingdom
  • Whitcher, Brandon, University of Westminster, London, England, United Kingdom
  • Bell, Jimmy D, University of Westminster, London, England, United Kingdom
  • Thomas, Elizabeth Louise, University of Westminster, London, England, United Kingdom
  • Howles, Sarah, University of Oxford Nuffield Department of Surgical Sciences, Oxford, England, United Kingdom
Background

Higher body-mass-index (BMI) and waist-hip ratio (WHR) increase kidney stone disease (KSD) risk. We hypothesised that adiposity alters renal fat depots to cause KSD.

Methods

Renal sinus fat volumes (RSF) were measured in 3D-MRI data (UK Biobank). KSD was defined using ICD, OPCS, primary care, and self-report codes. Cox proportional hazards models assessed associations with incident KSD. Least Absolute Shrinkage and Selection Operator (LASSO) regression and stability selection identified determinants of RSF and KSD-relevant risk factors.
We investigated causality using Mendelian randomisation (MR) with genome-wide association studies of KSD (24,167 cases; 876,673 controls-UK Biobank/FinnGen), BMI and WHR (N=806,834 and 697,734, respectively-UK Biobank/GIANT), and urine sodium and creatinine (N=331,667 -UK Biobank).

Results

Of 52,951 participants with 3D-MRI data, 1,601 had prevalent and 95 had incident KSD. Higher RSF associates with KSD (HR=1.31, 95% CI=1.07-1.61, P<0.05, Fig 1), BMI, and WHR (ß=0.37 and 0.17, respectively; P<0.05). LASSO regression with stability selection identifies BMI, WHR, and urine sodium as predictors of RSF suggesting that changes in urine sodium may mediate effects of adiposity on KSD risk.
MR analyses reveal that higher BMI, not WHR, increases urine sodium (ß=6.93, p=8.13x10-27). After adjusting for urine creatinine, higher urine sodium increases KSD risk (OR per 43.24mmol/L higher urine sodium=1.03, 95%CI=1.02-1.05, p=2.00x10-4). Mediation MR indicates that natriuresis causes ~37% of the effect of BMI on KSD risk (Fig 2).

Conclusion

Adiposity influences KSD risk by altering RSF and urine sodium. Targeting adiposity-related changes in sodium excretion may prevent KSD.

Hazard ratios for incident kidney stone disease

Mediation-MR:effects of BMI on urine sodium & KSD

Funding

  • Commercial Support – This research was conducted using the UK Biobank Resource (Application Numbers 44584 and 83942).

Digital Object Identifier (DOI)